Osteocalcin is associated with triglyceride glucose index rather than HOMA-IR in men with type 2 diabetes

IntroductionThe involvement of osteocalcin in the regulation of glucose tolerance in humans is controversial. We utilized a novel and practical insulin resistance surrogate, the triglyceride-glucose (TyG) index, to investigate the association between serum osteocalcin and insulin resistance in men w...

Full description

Bibliographic Details
Main Authors: Huijie Huang, Ai Wang, Li Cong, Yingjuan Zeng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.1067903/full
_version_ 1828114868766507008
author Huijie Huang
Ai Wang
Li Cong
Yingjuan Zeng
author_facet Huijie Huang
Ai Wang
Li Cong
Yingjuan Zeng
author_sort Huijie Huang
collection DOAJ
description IntroductionThe involvement of osteocalcin in the regulation of glucose tolerance in humans is controversial. We utilized a novel and practical insulin resistance surrogate, the triglyceride-glucose (TyG) index, to investigate the association between serum osteocalcin and insulin resistance in men with type 2 diabetes (T2D).MethodsThis was a retrospective cross-sectional study that included 667 male patients suffering from T2D, with measurements of N-terminal mid-fragment of osteocalcin (N-MID), triglycerides (TG), fasting blood glucose (FBG) and C-peptide collected on the same day. We used the TyG index and HOMA-IR as surrogate measures for insulin resistance. Binary logistic regression models that adjust the sociodemographic characteristics and metabolism-related factors were used to assess the associations between osteocalcin and insulin resistance. Restricted cubic spline (RCS) analysis was used to test the potential non-linear relationship between N-MID and the risk of severe insulin resistance. Subgroup analysis evaluated the robustness of the association.ResultsN-MID was correlated with the level of insulin resistance when quantified by the TyG index in unadjusted and adjusted binary logistic regression models (all p < 0.05), but the relationship was not observed when assessed by HOMA-IR (all p > 0.05). RCS model further confirmed that the association between N-MID and the severe insulin resistance measured by the TyG index was non-linear (P = 0.047). Subgroup analysis showed that the association was detected only in younger patients with lower BMI and poorer glycemic control, without hypertension or smoking.ConclusionsOsteocalcin was inversely associated with the TyG index in men with T2D.
first_indexed 2024-04-11T12:32:51Z
format Article
id doaj.art-ea99bede59c549bf83a76093df5713b0
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-11T12:32:51Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-ea99bede59c549bf83a76093df5713b02022-12-22T04:23:43ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-12-011310.3389/fendo.2022.10679031067903Osteocalcin is associated with triglyceride glucose index rather than HOMA-IR in men with type 2 diabetesHuijie HuangAi WangLi CongYingjuan ZengIntroductionThe involvement of osteocalcin in the regulation of glucose tolerance in humans is controversial. We utilized a novel and practical insulin resistance surrogate, the triglyceride-glucose (TyG) index, to investigate the association between serum osteocalcin and insulin resistance in men with type 2 diabetes (T2D).MethodsThis was a retrospective cross-sectional study that included 667 male patients suffering from T2D, with measurements of N-terminal mid-fragment of osteocalcin (N-MID), triglycerides (TG), fasting blood glucose (FBG) and C-peptide collected on the same day. We used the TyG index and HOMA-IR as surrogate measures for insulin resistance. Binary logistic regression models that adjust the sociodemographic characteristics and metabolism-related factors were used to assess the associations between osteocalcin and insulin resistance. Restricted cubic spline (RCS) analysis was used to test the potential non-linear relationship between N-MID and the risk of severe insulin resistance. Subgroup analysis evaluated the robustness of the association.ResultsN-MID was correlated with the level of insulin resistance when quantified by the TyG index in unadjusted and adjusted binary logistic regression models (all p < 0.05), but the relationship was not observed when assessed by HOMA-IR (all p > 0.05). RCS model further confirmed that the association between N-MID and the severe insulin resistance measured by the TyG index was non-linear (P = 0.047). Subgroup analysis showed that the association was detected only in younger patients with lower BMI and poorer glycemic control, without hypertension or smoking.ConclusionsOsteocalcin was inversely associated with the TyG index in men with T2D.https://www.frontiersin.org/articles/10.3389/fendo.2022.1067903/fullosteocalcininsulin resistancetriglyceride glucose indexHOMA-IRdiabetes
spellingShingle Huijie Huang
Ai Wang
Li Cong
Yingjuan Zeng
Osteocalcin is associated with triglyceride glucose index rather than HOMA-IR in men with type 2 diabetes
Frontiers in Endocrinology
osteocalcin
insulin resistance
triglyceride glucose index
HOMA-IR
diabetes
title Osteocalcin is associated with triglyceride glucose index rather than HOMA-IR in men with type 2 diabetes
title_full Osteocalcin is associated with triglyceride glucose index rather than HOMA-IR in men with type 2 diabetes
title_fullStr Osteocalcin is associated with triglyceride glucose index rather than HOMA-IR in men with type 2 diabetes
title_full_unstemmed Osteocalcin is associated with triglyceride glucose index rather than HOMA-IR in men with type 2 diabetes
title_short Osteocalcin is associated with triglyceride glucose index rather than HOMA-IR in men with type 2 diabetes
title_sort osteocalcin is associated with triglyceride glucose index rather than homa ir in men with type 2 diabetes
topic osteocalcin
insulin resistance
triglyceride glucose index
HOMA-IR
diabetes
url https://www.frontiersin.org/articles/10.3389/fendo.2022.1067903/full
work_keys_str_mv AT huijiehuang osteocalcinisassociatedwithtriglycerideglucoseindexratherthanhomairinmenwithtype2diabetes
AT aiwang osteocalcinisassociatedwithtriglycerideglucoseindexratherthanhomairinmenwithtype2diabetes
AT licong osteocalcinisassociatedwithtriglycerideglucoseindexratherthanhomairinmenwithtype2diabetes
AT yingjuanzeng osteocalcinisassociatedwithtriglycerideglucoseindexratherthanhomairinmenwithtype2diabetes